CHECKPOINT CAPITAL L.P.

PrivateCIK: 1977548
Location

SAN FRANCISCO, CA

πŸ“‹ What this filing means

CHECKPOINT CAPITAL L.P. filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $165.88M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

16
Positions
$165.88M
Total AUM (reported)
7.90M
Total Shares

Allocation by class

TOTAL AUM$165.88M16 positions
COM$99.48M60.0%
SPONSORED ADR$35.33M21.3%
COM SHS$16.00M9.6%
COM NEW$15.07M9.1%

Portfolio Concentration

Top 358.2%4–1036.8%11–254.9%TOP 1095.1%0%100%
Top 3$96.60M58.2%
4–10$61.09M36.8%
11–25$8.19M4.9%

Top 3 weight

58.2%

Top 10 weight

95.1%

Voting Authority Distribution

Total shares with voting rights: 7.90M

Sole

Full voting authority

7.90M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole16
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings16
Rows:

RHYTHM PHARMACEUTICALS INC

SOLE
COM
Shares922.10K
TypeSH
Market value$37.86M
22.82%
Sole
922.10K
Shared
0.00
None
0.00

ARGENX SE

SOLE
SPONSORED ADR
Shares82.15K
TypeSH
Market value$35.33M
21.30%
Sole
82.15K
Shared
0.00
None
0.00

AXSOME THERAPEUTICS INC

SOLE
COM
Shares290.77K
TypeSH
Market value$23.41M
14.11%
Sole
290.77K
Shared
0.00
None
0.00

AVADEL PHARMACEUTICALS PLC

SOLE
COM SHS
Shares1.14M
TypeSH
Market value$16.00M
9.65%
Sole
1.14M
Shared
0.00
None
0.00

PROTAGONIST THERAPEUTICS INC

SOLE
COM
Shares355K
TypeSH
Market value$12.30M
7.42%
Sole
355K
Shared
0.00
None
0.00

CYTOKINETICS INC

SOLE
COM NEW
Shares190K
TypeSH
Market value$10.29M
6.21%
Sole
190K
Shared
0.00
None
0.00

PHATHOM PHARMACEUTICALS INC

SOLE
COM
Shares875K
TypeSH
Market value$9.01M
5.43%
Sole
875K
Shared
0.00
None
0.00

CORCEPT THERAPEUTICS INC

SOLE
COM
Shares244.75K
TypeSH
Market value$7.95M
4.79%
Sole
244.75K
Shared
0.00
None
0.00

ATYR PHARMA INC

SOLE
COM NEW
Shares1.95M
TypeSH
Market value$3.04M
1.83%
Sole
1.95M
Shared
0.00
None
0.00

PLIANT THERAPEUTICS INC

SOLE
COM
Shares232.20K
TypeSH
Market value$2.50M
1.50%
Sole
232.20K
Shared
0.00
None
0.00

KYMERA THERAPEUTICS INC

SOLE
COM
Shares82K
TypeSH
Market value$2.45M
1.48%
Sole
82K
Shared
0.00
None
0.00

CIDARA THERAPEUTICS INC

SOLE
COM NEW
Shares145.42K
TypeSH
Market value$1.74M
1.05%
Sole
145.42K
Shared
0.00
None
0.00

TREVI THERAPEUTICS INC

SOLE
COM
Shares500.09K
TypeSH
Market value$1.49M
0.90%
Sole
500.09K
Shared
0.00
None
0.00

APPLIED THERAPEUTICS INC

SOLE
COM
Shares227.47K
TypeSH
Market value$1.06M
0.64%
Sole
227.47K
Shared
0.00
None
0.00

SOLENO THERAPEUTICS INC

SOLE
COM
Shares19.70K
TypeSH
Market value$803.6K
0.48%
Sole
19.70K
Shared
0.00
None
0.00

ALLAKOS INC

SOLE
COM
Shares649.96K
TypeSH
Market value$650.0K
0.39%
Sole
649.96K
Shared
0.00
None
0.00
CHECKPOINT CAPITAL L.P. 13F Holdings β€” 16 Positions | Finecho